Mouse ES cells: Experimental exploitation of pluripotent differentiation potential

Current Opinion in Genetics and Development

Volumn 11, Issue 5, 2001, Pages 587-594

  Rathjen, Joy ^a   Rathjen, Peter D ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

BIOCHEMISTRY; CELL DIFFERENTIATION; CELL FATE; CELL ISOLATION; CELL LINEAGE; CELL MATURATION; CELL POPULATION; CELL TRANSPLANTATION; CYTOLOGY; EMBRYO CELL; EMBRYO DEVELOPMENT; GENE FUNCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL;

EID: 0035479915     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(00)00237-9     Document Type: Review

References (81)

1. Mouse embryo stem cells: Their identification, propagation and manipulation
2. Properties and uses of embryonic stem cells: Prospects for application to human biology and gene therapy
3. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells
4. Establishment in culture of pluripotential cells from mouse embryos
5. The origin and efficient derivation of embryonic stem cells in the mouse
6. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides
7. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells
8. Establishment of germ-line-competent embryonic stem (ES) cells using differentiation inhibiting activity
9. Isolation of embryonic stem (ES) cells in media supplemented with recombinant leukemia inhibitory factor (LIF)
10. Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations
11. Ciliary neurotrophic factor maintains the pluripotentiality of embryonic stem cells
12. Derivation of germline competent embryonic stem cells with a combination of interleukin-6 and soluble interleukin-6 receptor
13. Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro
14. Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways
15. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signalling complex
16. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells
17. The carboxyl-terminal domains of gp130-related cytokine receptors are necessary for suppressing embryonic stem cell differentiation
18. Complementary tissue-specific expression of LIF and LIF-receptor mRNAs in early mouse embryogenesis
19. Essential function of LIF receptor in motor neurons
20. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death
21. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders
22. Paracrine induction of stem cell renewal by LIF-deficient cells: A new ES cell regulatory pathway
23. Mouse embryonic stem (ES) cell lines established from neuronal cell-derived cloned blastocysts
24. Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei
25. Selective ablation of differentiated cells permits isolation of embryonic stem cell lines from murine embryos with a non-permissive genetic background
26. Maintenance of pluripotential embryonic stem cells by stem cell selection
27. Formation of a primitive ectoderm like cell population, EPL cells, from ES cells in response to biologically derived factors
28. Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells
29. mTert expression correlates with telomerase activity during the differentiation of murine embyronic stem cells
30. The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo
31. Altered imprinted gene methylation and expression in completely ES cell-derived mouse fetuses: Association with aberrant phenotypes
32. Developmental complexity of early mammalian pluripotent cell populations in vivo and in vitro
33. The in vitro development of blastocyst-derived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium
34. mRNA localization studies suggest that murine FGF-5 plays a role in gastrulation
35. Signals for death and survival: A two-step mechanism for cavitation in the vertebrate embryo
36. Regeneration of endoderm from primitive ectoderm in the mouse embryo: Fact or artifact?
37. Immortal germ cells?
38. Effect of Steel factor and leukemia inhibitory factor on murine primordial germ cells in culture
39. Long-term proliferation of mouse primordial germ cells in culture
40. BMP signalling plays a role in visceral endoderm differentiation and cavitation in the early mouse embryo
41. Fibroblast growth factor (FGF) signalling through PI 3-kinase and Akt/PKB is required for embryoid body differentiation
42. Regulation of programmed cell death by basement membranes in embryonic development
43. Reversible programming of pluripotent cell differentiation
44. 1 integrin-deficient embryonal stem cells to differentiate into keratinocytes
45. Absence of basement membranes after targeting the LAMC1 gene results in embryonic lethality due to failure of endoderm differentiation
46. Acommon precursor for hematopoietic and endothelial cells
47. + VE-cadherin? cells at a diverging point of endothelial and hemopoietic lineages
48. A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1
49. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors
50. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells
51. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a
52. Primary non-random X inactivation associated with disruption of Xist promoter regulation
53. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells
54. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4
55. Huntingtin is required for normal hematopoiesis
56. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages
57. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene
58. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL
59. Genotype-based screen for ENU-induced mutations in mouse embryonic stem cells
60. Mouse mutants from chemically mutagenized embryonic stem cells
61. Embryonic stem cells express neuronal properties in vitro
62. Generation of purified neural precursors from embryonic stem cells by lineage selection
63. Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro
64. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts
65. Selection of ventricular-like cardiomyocytes from ES cells in vitro
66. Directed differentiation of dendritic cells from mouse embryonic stem cells
67. Generation of lymphohematopoietic cells from embryonic stem cells in culture
68. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity
69. Embryonic stem cell-derived glial precursors: A source of myelinating transplants
70. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells
71. Differentiation of green fluorescent protein-labelled embryonic stem cell-derived neural precursor cells into Thy-1-positive neurons and glia after transplantation into adult rat striatum
72. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord
73. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation
74. In vivo immunological function of mast cells derived from embryonic stem cells: An approach for the rapid analysis of even embryonic lethal mutations in adult mice in vivo
75. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice
76. Lineage specific differentiation of pluripotent cells in vitro: A role for extraembryonic cell types
77. Anterior patterning in mouse
78. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer
79. Epigenetic instability in ES cells and cloned mice
80. Direct neural fate specification from embryonic stem cells: A primitive mammalian neural stem cell stage acquired through a default mechanism
81. Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors